Literature DB >> 32278572

Assessment of primary outcome measures for a clinical trial of pediatric hemorrhagic injuries.

Daniel K Nishijima1, Melissa Gosdin2, Hiba Naz3, Daniel J Tancredi4, Hilary A Hewes5, Sage R Myers6, Rachel M Stanley7, P David Adelson8, Randall S Burd9, Yaron Finkelstein10, John VanBuren11, T Charles Casper12, Nathan Kuppermann13.   

Abstract

OBJECTIVE: We evaluated the acceptability of the Pediatric Quality of Life Inventory (PedsQL) and other outcomes as the primary outcomes for a pediatric hemorrhagic trauma trial (TIC-TOC) among clinicians.
METHODS: We conducted a mixed-methods study that included an electronic questionnaire followed by teleconference discussions. Participants confirmed or rejected the PedsQL as the primary outcome for the TIC-TOC trial and evaluated and proposed alternative primary outcomes. Responses were compiled and a list of themes and representative quotes was generated.
RESULTS: 73 of 91 (80%) participants completed the questionnaire. 61 (84%) participants agreed that the PedsQL is an appropriate primary outcome for children with hemorrhagic brain injuries. 32 (44%) participants agreed that the PedsQL is an acceptable primary outcome for children with hemorrhagic torso injuries, 27 (38%) participants were neutral, and 13 (18%) participants disagreed. Several themes were identified from responses, including that the PedsQL is an important and patient-centered outcome but may be affected by other factors, and that intracranial hemorrhage progression assessed by brain imaging (among patients with brain injuries) or blood product transfusion requirements (among patients with torso injuries) may be more objective outcomes than the PedsQL.
CONCLUSIONS: The PedsQL was a well-accepted proposed primary outcome for children with hemorrhagic brain injuries. Traumatic intracranial hemorrhage progression was favored by a subset of clinicians. A plurality of participants also considered the PedsQL an acceptable outcome for children with hemorrhagic torso injuries. Blood product transfusion requirement was favored by fewer participants.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children; Consensus; Outcome measure; Pediatric Quality of Life; Tranexamic acid; Trauma

Mesh:

Year:  2020        PMID: 32278572      PMCID: PMC7483869          DOI: 10.1016/j.ajem.2020.03.001

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  Traumatic injury clinical trial evaluating tranexamic acid in children (TIC-TOC): a pilot randomized trial.

Authors:  Daniel K Nishijima; John M VanBuren; Seth W Linakis; Hilary A Hewes; Sage R Myers; Matthew Bobinski; Nam K Tran; Simona Ghetti; P David Adelson; Ian Roberts; James F Holmes; Walton O Schalick; J Michael Dean; T Charles Casper; Nathan Kuppermann
Journal:  Acad Emerg Med       Date:  2022-03-10       Impact factor: 5.221

2.  The design of a Bayesian adaptive clinical trial of tranexamic acid in severely injured children.

Authors:  John M VanBuren; T Charles Casper; Daniel K Nishijima; Nathan Kuppermann; Roger J Lewis; J Michael Dean; Anna McGlothlin
Journal:  Trials       Date:  2021-11-04       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.